1. HBW Insight
  2. >>Supply Chain

Nestlé Hit By US Supply Chain Issue Expected To Impact VMS Sales Into 2024

 
• By Tom Gallen

Nestlé insists it is “on top of” an unexpected supply chain problem which emerged in the US in August and has since hit sales of its dietary supplements in North America. The company revealed the issue as it reported flat sales at its Health Science business for the opening nine months of 2023.

Supply Chain Issues Text With Chain Image
• Source: Shutterstock

Nestlé Health Science has been blindsided by a supply chain problem impacting vitamin, mineral and supplement sales in North America.

An IT integration issue which surfaced in August during work to consolidate its US VMS packaging sites led to supply...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Supply Chain

Latest Tariff Changes Won’t Be The Last Industry And Consumers Should Expect From Trump

 
• By Malcolm Spicer

“With this administration the policy changes are every other week and tend to get delayed or pushed out and whatnot,” says Tax Foundation analyst Alex Durante. Additional tariff rate changes varying by country for imports from around the world take effect on Aug. 7.

Growing With Purpose – Inside Kenvue’s ‘Healthy Lives Mission’

 
• By David Ridley

HBW Insight speaks to Kenvue's global head of sustainability, Jennifer Duran, about the company's “Healthy Lives Mission,” including insights into how the firm is decarbonizing its supply chain, reducing the use of plastics and embedding sustainability into the design of new products.

Wellness Firms Targeting GLP-1 Patients’ Dietary Needs Keep Option To Provide Access To Oral Rx

Health and wellness brands and retail chains providing access to prescriptions for compounded GLP-1 drugs, most also offering supplements curated to help meet dietary needs of GLP-1 patients, are offering formulations in oral form as well as injection.

Over The Counter: EU Omnibus And ESG, What You Need To Know, With CEN Group’s Jasper Crone

 
• By David Ridley

HBW Insight catches up with sustainability expert Jasper Crone to find out what consumer health companies need to know about the European Commission's Omnibus simplification package.

More from HBW Insight

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By Tom Gallen

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

From ‘Work Harder’ to ‘Phenomenal People’: Makary’s FDA About-Face

 
• By Michael McCaughan

In his first 100 days as FDA commissioner, Martin Makary has gone from vocal critic to vocal supporter of the agency’s staff, calling them “phenomenal” and praising their dedication—even as morale remains shaken by recent layoffs and restructuring.

Church & Dwight’s Options For Vitamin Brands: Divest, Find Partner, Shrink Business

 
• By Malcolm Spicer

Divesting C&D’s vitamin business, says CEO Richard Dierker, is “probably the cleanest option” as brands remain a drag on earnings after second quarter.